Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer D Wu

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Minerva Anestesiologica|April 7, 2018
Preoperative anxiety and implications on postoperative recovery: what can we do to change our historyDusica M Stamenkovic, Nemanja K Rancic, Milan B Latas, et al.
Cytokine & Growth Factor Reviews|September 1, 2016
The CXCL8-CXCR1/2 pathways in cancerQian Liu, Anping Li, Yijun Tian, et al.
Journal of Hematology & Oncology|November 9, 2016
The expression profile and clinic significance of the SIX family in non-small cell lung cancerQian Liu, Anping Li, Yijun Tian, et al.
Biomedicines|January 23, 2024
The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent ModesAnthony V Serritella, Pablo Saenz-Lopez Larrocha, Payal Dhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumorsJennifer D Wu, Kathy Haugk, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancerStephen R Plymate, Kathy Haugk, Ilsa Coleman, et al.
Communications Biology|July 23, 2021
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationPayal Dhar, Fahmin Basher, Zhe Ji, et al.
Clinical Colorectal Cancer|January 10, 2017
Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older PatientsKristin Wallace, Allan DeToma, David N Lewin, et al.
The Journal of Clinical Investigation|September 11, 2013
Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasisGang Liu, Shengjun Lu, Xuanjun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor InhibitionCynthia C T Sprenger, Kathleen Haugk, Shihua Sun, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Minerva Anestesiologica|April 7, 2018
Preoperative anxiety and implications on postoperative recovery: what can we do to change our historyDusica M Stamenkovic, Nemanja K Rancic, Milan B Latas, et al.
Cytokine & Growth Factor Reviews|September 1, 2016
The CXCL8-CXCR1/2 pathways in cancerQian Liu, Anping Li, Yijun Tian, et al.
Journal of Hematology & Oncology|November 9, 2016
The expression profile and clinic significance of the SIX family in non-small cell lung cancerQian Liu, Anping Li, Yijun Tian, et al.
Biomedicines|January 23, 2024
The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent ModesAnthony V Serritella, Pablo Saenz-Lopez Larrocha, Payal Dhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumorsJennifer D Wu, Kathy Haugk, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancerStephen R Plymate, Kathy Haugk, Ilsa Coleman, et al.
Communications Biology|July 23, 2021
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationPayal Dhar, Fahmin Basher, Zhe Ji, et al.
Clinical Colorectal Cancer|January 10, 2017
Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older PatientsKristin Wallace, Allan DeToma, David N Lewin, et al.
The Journal of Clinical Investigation|September 11, 2013
Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasisGang Liu, Shengjun Lu, Xuanjun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor InhibitionCynthia C T Sprenger, Kathleen Haugk, Shihua Sun, et al.
Pageof 5